In this study, we evaluated the therapeutic efficacy of recombinant BMP9 in NAFLD mice and found that exogenous supplementation of BMP9 reduced obesity and hepatic steatosis and improved glucose metabolism. Here, GDF2 is linked to Hepatic steatosis.